Gene therapy that decreases light and HIV to the AIDS treatment and an excellent result.

The treatment experiment is done to five patients in this experiment. Virus "VRX496" for the treatment that VIRxSYS (Barcshis) Co. of the venture company in United States Maryland state had developed was administered. The gene connected from HIV with the pathogenicity is deleted, and the gene of "antisense" that obstructs the protein synthesis of HIV instead is built into this. In short, "Virus that removed the proliferation element of malignant and HIV. "

In a word, the idea of proliferating the one with the mechanism that the virus that removes a malignant part of not the attack of HIV in treatment now but HIV replaces HIV. Will the rat is not attacked directly but do it do in the rat extermination and be setting loose of the rat of an unpleasant cat to the field though the comparison might be too a leap?

Immunocyte "CD4" that becomes the target of HIV from five patients (Fail in other antiviral treatments) is taken out in the medicine research team, VRX496 is infected, and it proliferates. It returns to each one's inside of the body after it scolds and the appearance is observed. The result that the number of CD4 increased even up to four people in the result and five people after one year, and HIV decreased in addition in three people was obtained.

It is said that the influence will not appear to patients at present though this experiment confirms the safety of VRX496 to the end, and three years pass from the verification beginning actually either. In the research team｢It is necessary already to see the appearance for a while. Moreover, this VRX496 cannot really fix whether causing the immunity the recovery. The clinical trial person more than the future is needed. ｣It comments.

Carefulness more than enough is needed, and time is also considerable or driving doesn't have the method because the experiment intended for the human body. However, it is also true that the beacon of hope came into view for the person related to HIV. I want to expect progress information on study results in the future.